YU57800A - Preventivno i terapeutsko sredstvo za kost i hrskavicu koje sadrži derivat barbiturne kiseline - Google Patents
Preventivno i terapeutsko sredstvo za kost i hrskavicu koje sadrži derivat barbiturne kiselineInfo
- Publication number
- YU57800A YU57800A YU57800A YU57800A YU57800A YU 57800 A YU57800 A YU 57800A YU 57800 A YU57800 A YU 57800A YU 57800 A YU57800 A YU 57800A YU 57800 A YU57800 A YU 57800A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- substituted
- acid derivative
- barbituric acid
- bone
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ovaj pronalazak se odnosi na derivat barbiturne kiseline prikazan formulom (I) gde R ili R1 svaki nezavisno predstavlja atom vodonika, supstituisanu ili nesupstituisanu alkil grupu, ili alkenil grupu sa C1-C15, supstituisanu ili nesupstituisanu arilmetil grupu, ili supstituisanu ili nesupstituisanu aril grupu, a R2 predstavlja supstituisanu ili nesupstituisanu alkil grupu ili alkenil grupu sa C1-C15, supstituisanu ili nesupstituisanu arilmetil grupu, ili supstituisanu ili nesupstituisanu aril grupu. Derivat barbiturne kiseline iz ovog pronalaska ima jako inhibiciono dejstvo na resorpciju kosti i koristan je kao preventivno ili terapeutsko sredstvo za bolesti koje napadaju kost i hrskavicu.[The present invention relates to a barbituric acid derivative shown in formula (I) (wherein R or R1 independently represents a hydrogen atom, a substituted or not substituted alkyl group or alkenyl group of C1 - C15, a substituted or not substituted arylmethyl group, and substituted or not substituted aryl group, and R2 represents substituted or not substituted alkyl group or alkenyl group of C1 - C15, a substituted or not substituted arylmethyl group, and substituted or not substituted aryl group). The barbituric acid derivative of the present invention has a strong inhibiting activity to bone resorption and is useful as a preventive and therapeutic agent for diseases affecting bone and cartilage.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10100355A JPH11279157A (ja) | 1998-03-27 | 1998-03-27 | バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU57800A true YU57800A (sh) | 2002-10-18 |
Family
ID=14271794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU57800A YU57800A (sh) | 1998-03-27 | 1999-03-23 | Preventivno i terapeutsko sredstvo za kost i hrskavicu koje sadrži derivat barbiturne kiseline |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6498164B1 (sh) |
| EP (1) | EP1064269A1 (sh) |
| JP (1) | JPH11279157A (sh) |
| KR (1) | KR20010042182A (sh) |
| CN (1) | CN1295565A (sh) |
| AU (1) | AU759249B2 (sh) |
| BR (1) | BR9909139A (sh) |
| CA (1) | CA2324584A1 (sh) |
| CZ (1) | CZ20003460A3 (sh) |
| EA (1) | EA200000992A1 (sh) |
| HU (1) | HUP0101505A3 (sh) |
| IL (1) | IL138433A0 (sh) |
| NO (1) | NO20004798L (sh) |
| NZ (1) | NZ506616A (sh) |
| PL (1) | PL343433A1 (sh) |
| SK (1) | SK14032000A3 (sh) |
| TR (1) | TR200002785T2 (sh) |
| WO (1) | WO1999050252A2 (sh) |
| YU (1) | YU57800A (sh) |
| ZA (1) | ZA200004473B (sh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082079A2 (en) * | 2004-02-26 | 2005-09-09 | Inotek Pharmaceuticals Corporation | Tetracyclic lactam derivatives and uses thereof |
| CN102070623B (zh) * | 2010-12-20 | 2012-07-25 | 新乡医学院 | 一种巴比妥酸衍生物及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2921072A (en) * | 1956-10-18 | 1960-01-12 | Jr Edgar A Ferguson | Nicotinic acid substituents of barbituric acid |
| GB1339748A (en) * | 1970-07-02 | 1973-12-05 | Ici Ltd | Pyrimidine derivatives |
| JPS5829281B2 (ja) * | 1974-06-04 | 1983-06-22 | 日本曹達株式会社 | バルビツ−ル酸系除草剤 |
| US4695673A (en) * | 1985-11-20 | 1987-09-22 | Stauffer Chemical Company | Process for the production of acylated 1,3-dicarbonyl compounds |
| US4797147A (en) * | 1986-06-09 | 1989-01-10 | Stauffer Chemical Company | Herbicidal method and composition utilizing certain 5-(2-substituted benzoyl)-barbituric acids |
| US4938796A (en) * | 1987-07-06 | 1990-07-03 | Ici Americas Inc. | Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and antidotes therefor |
| JP2588779B2 (ja) * | 1989-09-18 | 1997-03-12 | 富士写真フイルム株式会社 | 電子写真式製版用印刷原版 |
| US5102760A (en) * | 1989-09-18 | 1992-04-07 | Fuji Photo Film Co., Ltd. | Electrophotographic photoreceptor and electrophotographic printing plate precursor comprising phthalocyanine pigment and thiobarbituric acid derivative |
| JP2588780B2 (ja) * | 1989-09-26 | 1997-03-12 | 富士写真フイルム株式会社 | 電子写真感光体 |
| JPH03179361A (ja) * | 1989-12-07 | 1991-08-05 | Fuji Photo Film Co Ltd | 光導電性組成物およびそれを用いた電子写真感光材料 |
| US5141943A (en) * | 1990-04-12 | 1992-08-25 | Brown University Research Foundation | 5-benzyl barbiturate derivatives |
| NL9001075A (sh) * | 1990-05-04 | 1991-12-02 | Duphar Int Res | |
| DK0517660T3 (da) * | 1991-06-05 | 1997-10-27 | Ciba Geigy Ag | Benzo-1,2,3-thiadiazol-derivater. |
| EP0809634A4 (en) * | 1995-02-13 | 1998-05-20 | Kirpal S Gulliya | NEW USES FOR BARBITURIC ACID ANALOGS |
| JPH10316608A (ja) * | 1997-05-14 | 1998-12-02 | Hoechst Yakuhin Kogyo Kk | ポリヒドロキシフェノール誘導体およびそれらからなる骨・軟骨疾患予防・治療剤 |
-
1998
- 1998-03-27 JP JP10100355A patent/JPH11279157A/ja active Pending
-
1999
- 1999-03-23 IL IL13843399A patent/IL138433A0/xx unknown
- 1999-03-23 US US09/647,280 patent/US6498164B1/en not_active Expired - Fee Related
- 1999-03-23 HU HU0101505A patent/HUP0101505A3/hu unknown
- 1999-03-23 SK SK1403-2000A patent/SK14032000A3/sk unknown
- 1999-03-23 TR TR2000/02785T patent/TR200002785T2/xx unknown
- 1999-03-23 PL PL99343433A patent/PL343433A1/xx unknown
- 1999-03-23 EP EP99919495A patent/EP1064269A1/en not_active Withdrawn
- 1999-03-23 CN CN99804571A patent/CN1295565A/zh active Pending
- 1999-03-23 NZ NZ506616A patent/NZ506616A/xx unknown
- 1999-03-23 BR BR9909139-9A patent/BR9909139A/pt not_active IP Right Cessation
- 1999-03-23 WO PCT/IB1999/000961 patent/WO1999050252A2/en not_active Application Discontinuation
- 1999-03-23 EA EA200000992A patent/EA200000992A1/ru unknown
- 1999-03-23 CZ CZ20003460A patent/CZ20003460A3/cs unknown
- 1999-03-23 AU AU37260/99A patent/AU759249B2/en not_active Ceased
- 1999-03-23 YU YU57800A patent/YU57800A/sh unknown
- 1999-03-23 KR KR1020007010669A patent/KR20010042182A/ko not_active Application Discontinuation
- 1999-03-23 CA CA002324584A patent/CA2324584A1/en not_active Abandoned
-
2000
- 2000-08-29 ZA ZA200004473A patent/ZA200004473B/xx unknown
- 2000-09-26 NO NO20004798A patent/NO20004798L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101505A2 (hu) | 2002-03-28 |
| NO20004798D0 (no) | 2000-09-26 |
| BR9909139A (pt) | 2000-12-05 |
| EP1064269A1 (en) | 2001-01-03 |
| AU3726099A (en) | 1999-10-18 |
| NZ506616A (en) | 2003-04-29 |
| ZA200004473B (en) | 2001-05-30 |
| TR200002785T2 (tr) | 2001-02-21 |
| SK14032000A3 (sk) | 2001-03-12 |
| IL138433A0 (en) | 2001-10-31 |
| US6498164B1 (en) | 2002-12-24 |
| CA2324584A1 (en) | 1999-10-07 |
| NO20004798L (no) | 2000-11-20 |
| WO1999050252A3 (en) | 2000-01-13 |
| AU759249B2 (en) | 2003-04-10 |
| WO1999050252A2 (en) | 1999-10-07 |
| JPH11279157A (ja) | 1999-10-12 |
| PL343433A1 (en) | 2001-08-13 |
| KR20010042182A (ko) | 2001-05-25 |
| EA200000992A1 (ru) | 2001-06-25 |
| CZ20003460A3 (cs) | 2001-08-15 |
| HUP0101505A3 (en) | 2002-06-28 |
| CN1295565A (zh) | 2001-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL128160A0 (en) | Purine derivatives and pharmaceutical compositions containing the same | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| AU1973997A (en) | Pentafluorobenzenesulfonamides and analogs | |
| EP0938317A4 (en) | COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION | |
| MXPA01011517A (es) | Nucleosidos de 4'-c-etinil-purina. | |
| TWI265929B (en) | Triazinyl derivatives for inhibiting the production of IL-12 | |
| EP0139534A3 (en) | Compositions for the prophylactic treatment of osteitis and osteomyelitis | |
| DE69612374T2 (de) | Derivate des carbapenem-3-carbonsäureesters | |
| HK1015766A1 (en) | 1-methylcarbapenem derivatives | |
| UA42837C2 (uk) | Спосіб модулювання кальцієвих каналів у судинній та серцевій тканині | |
| YU57800A (sh) | Preventivno i terapeutsko sredstvo za kost i hrskavicu koje sadrži derivat barbiturne kiseline | |
| TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
| PL329885A1 (en) | Derivatives of polyhydroxyphenol and agents containing them for use in prophylactics and treatment of bone and cartilage diseases | |
| ATE64095T1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| AU4544096A (en) | New derivatives of glycylanilides, preparation and therapeutical application |